With a wide selection of models, we can deliver timely and cost-effective improvements to your preclinical research programs.

We are offering a variety of in vivo toxicology tests that are more predictive of live organism response, enable faster turnaround times, provide discrete data on specific endpoints, and help select and rank chemicals for testing in specific targets.

Our different models are built to ensure that your PK/PD studies produce accurate, better and valid results. From the selection of animal models to the final analysis of PK/PD efficacy, our team of experts is ready to assist you. We ensure ethical animal handling and dosing appropriately after selection of right animal models. Accurate measurement of drug concentrations in different tissues, will ease data analysis and evaluation methods of PK/PD which ensures later efficacy of your drug prototype.

We are the only preclinical CRO providing tumor services using Cellular DNA double barcoding technology. In addition, we are offering CDX & PDX and syngeneic models, cellular screening platforms.

Our biomarker services include a wide range of assays such as ELISA, IHC, FACS, clinical chemistry, PCR and NGS-based genomics, bioinformatics and big data analysis.













We are offering the following models:

  • Toxicology testing, MTD & PD/PK testing
  • Patient-Derived Xenograft (PDX) Models
  • Cell line-derived xenograft (CDX) models
  • Syngeneic Mouse Models
  • Immune Mediated Inflammatory Disease Models:

o          Type 1 Diabetes (T1D) In Vivo Models

o          Type 2 Diabetes (T1D) In Vivo Models

o          Multiple Sclerosis (MS) Models

o          Peritonitis Models

  • Microbiota and gastrointestinal disease models